publication date: Apr. 13, 2018

Funding Opportunities DOD Ovarian Cancer Research Program Publishes funding opportunities

FY18 OCRP Program Announcements and General Application Instructions for the following award mechanisms are posted on


Clinical Development Award

Letter of Intent due July 25, 2018

Must be an independent investigator at or above the level of Assistant Professor (or equivalent).

Supports the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life.

Near-term impact is expected.

Preclinical studies in animals are not allowed.

Small-scale clinical trials (Phase 0, phase I, Pilot), studies enriching a clinical trial, and projects related to or associated with ongoing or completed clinical trials are allowed.

Preliminary data are required.

Optional Nested Early-Career Investigator:  Applications proposing clinical trials and having an ECI that meets the criteria outlined in the Program Announcement/Funding Opportunity will qualify for a higher level of funding.

NEW: Submission of a Letter of Intent is required prior to full application submission.

Maximum funding of $600,000 for direct costs (plus indirect costs).

With ECI option the maximum funding is $800,000 for direct costs (plus indirect costs).

Maximum period of performance is 3 years.


Omics Consortium … Continue reading DOD Ovarian Cancer Research Program Publishes funding opportunities

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.